Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 12 years
- Director since
- 2023
12 years of board service in total across 4 boards, counting each seat separately. Longest: Precigen Inc., 3 years.
Precigen Inc.
Director
Cocrystal Pharma Inc.
Director
BridgeBio Pharma Inc.
Director
EyePoint Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cocrystal Pharma Inc. July 14, 202696.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Mar 13, 2026 | Precigen Inc. | Option exercise | +71,839 | — | — |
| Mar 10, 2026 | Precigen Inc. | Grant or award | +17,948 | $3.51 | $62,997 |
| Oct 28, 2025 | Cocrystal Pharma Inc. | Grant or award | +359,713 | $1.39 | $500,001 |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| Mar 14, 2025 | Precigen Inc. | Option exercise | +87,412 | — | — |
| Mar 13, 2025 | Precigen Inc. | Grant or award | +36,206 | $1.74 | $62,998 |
| Oct 9, 2024 | Cocrystal Pharma Inc. | Grant or award | +8,067 | — | — |
| Mar 14, 2024 | Precigen Inc. | Grant or award | +44,055 | $1.43 | $62,999 |
| Mar 9, 2024 | Precigen Inc. | Option exercise | +106,837 | — | — |
| Aug 14, 2023 | Precigen Inc. | Open-market purchase | +570,345 | $1.75 | $998,104 |
| Mar 9, 2023 | Precigen Inc. | Grant or award | +48,290 | $1.17 | $56,499 |
| Feb 22, 2023 | Precigen Inc. | Option exercise | +61,576 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.